Use of adjuvanted trivalent influenza vaccine in older-age adults: a systematic review of economic evidence

• Prif Awduron: Ilaria Loperto (Awdur), Andrea Simonetti (Awdur), Antonio Nardone (Awdur), Maria Triassi (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Taylor & Francis Group, 2019-05-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Seasonal influenza is a very common disease. Yearly vaccination of at-risk population groups is a well-recognized cost-effective/cost-saving preventive measure. It is, however, unclear which available alternative has the most favorable economic profile. Some available options are: trivalent (TIV) an...